McLoughlin Margaret 4
4 · Quince Therapeutics, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
McLoughlin Margaret
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-02+31,613→ 31,613 totalExercise: $1.88Exp: 2035-01-02→ Common Stock (31,613 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy.